PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 10.05
-0.05 (-0.50%)
Aug 12, 2025, 1:57 PM CST
PlexBio Revenue
In the year 2024, PlexBio had annual revenue of 128.06M TWD, down -23.40%. PlexBio had revenue of 94.79M in the half year ending December 31, 2024, with 14.03% growth.
Revenue
128.06M
Revenue Growth
-23.40%
P/S Ratio
8.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 128.06M | -39.11M | -23.40% |
| Dec 31, 2023 | 167.18M | -24.01M | -12.56% |
| Dec 31, 2022 | 191.19M | 66.25M | 53.02% |
| Dec 31, 2021 | 124.94M | 23.60M | 23.28% |
| Dec 31, 2020 | 101.35M | 30.17M | 42.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.67B |